Cytogenetics

Human Cytogenetics Index

3 Prenatal Diagnostics

6 Postnatal Diagnostics 6 - Bone Marrow Culture 8 - Blood lymphocyte Culture 10 - Lymphocyte Separation Tubes

13 Karyotyping Reagents

2 Prenatal Diagnostics 3 field ‭ ‬ Samples ) ‬ ‭ CV (‬ and BIOAMF-3, which are selling very successfully throughout throughout successfully very selling are which BIOAMF-3, and ‬ the world. which can be cell cultured to obtain mitotic cells. mitotic obtain to cultured be cell which can include and fetus the from originate cells fluid amniotic Most suited cells The amniocytes. and cells epithelial fibroblasts, for genetic analysis are fibroblasts and amniocytes, and chromosome preparation from these cells yields a clear observation. microscopic for of the chromosomes picture Amniocentesis is typically carried out in week 16-20 of when pregnancy, for genetic analysis. 20-40ml of amniotic fluid is drawn obtain to flasks suitable in or slide a on seeded be can cells The chromosome divide, cells the Since cultures. cell or colonies genetic general for them on out carried be can karyotyping testing. test To specific abnormalities, a small number of cells can be taken from the original sample for FISH and/ or QF-PCR testing. The time that elapses until the finalresults of from genetic both importance significant of is obtained are analysis entailed stress and tension the – view of point emotional an in waiting for the finalresults - and a practical one - the need to terminate pregnancy if genetic abnormalities are found. Pregnancy termination in the second trimester in importance the hence abortion; an performing means effect alleviate to order in possible as early as results obtaining of the procedure. a developed has Ltd. Industries Biological decade, past the In of culture for media including products, cytogenetics of range BIOAMF-2 BIOAMF-1, cells, villi chorionic and fluid amniotic Prenatal Diagnostics Prenatal Optimized Medium for Culture and Genetic Analysis of Human Amniotic Fluid Cells and Chorionic Villi‭ Chromosome Karyotyping was first developed in the of Cytogenetics. The basic principle of the method is the preparation of chromosomes for microscopic observation by arresting cell mitosis at metaphase with colchicine and treating the cells with a hypotonic solution. This is by followed regular then are which chromosomes, the of staining fluorescent or programs computer and microscope a of aid the with tested to arrange and identify the the for presence chromosomes of genetic abnormalities. In principle, this method enables the identificationany abnormalityof - excess chromosomes or chromosome material genetic excess or chromosomes, broken deficiency, process). recombination of a (as a result Clinical cytogenetics laboratories use this method with amniotic fluid, chorionic villi, bloodcells, skincells, etc. ‬ ‭), >12 12 11 ‬recommended ‭ ( Unit Size 500ml 100ml ) and closed systems. closed and ) 2 10 BIOAMF™-2 Leading Competitor Leading Competitor BIOAMF™-2 9 Harvest Day Harvest 8 Cat. No. 01-194-1A 01-194-1B ‬ 7 ‬ 6 ‬after thawing at R.T or 4°C ‭, 5

: Comparison of the Percentage of Harvested Plates . ‬

5 0

35 30 25 20 15 10 50 45 40 % Harvested Plates Harvested % dispense into aliquots to avoid repeated freezing and thawing thawing and freezing repeated avoid to aliquots into dispense ‭ cycles light. from the medium Protect Figure According To Harvest Day Between Biological Industries and a Leading Competitor BIOAMF™-2 If required ‭ BIOAMF-2 Medium Complete results faster For Name Product the for optimized specifically medium complete a is BIOAMF-2 chorionic and cells fluid amniotic human of culture primary CO (5% open both in samples (CV) villi karyotyping chromosome and required, is serum of addition No time is greatly reduced compared with the conventional medium. Note: this is a one-bottle formulation, which also contains thaw and use! ‬ and antibiotics. Simply L-Glutamine ‭ and Stability Storage at -20°C. frozen Medium should be kept BIOAMF-2 at 2-8°C. thawing, the medium should be stored After thawing. after The medium should be used within 7 days BIOAMF-2 Medium Complete ‬ Unit Size 450ml 90ml 10ml 50ml Cat. No. 01-190-1A 01-190-1B 01-192-1D 01-192-1E ‬ ‬

) and closed systems. ) and closed 2 production date when stored at 2-8ºC. when stored date production production from months 24 for stable is Supplement BIOAMF-1 at -20ºC. when stored date medium The for 14 is complete days stable at when stored 2-8ºC. medium. the complete Do not freeze Protect both the basal medium and the complete medium light.‬ from ‭ and Stability Storage BIOAMF-1 Basal Medium is stable for 15 months from 03-020-1). Antibiotics may be added if desired (Gentamicin, Cat. No. 03-035-1).‬ bath, and transfer the contents to the bottle of BIOAMF-1 Basal Medium. Mix the complete medium by swirling the bottle, and add 2mM L-Glutamine (L-Glutamine Solution 200mM, cat. no. For the preparation of 100ml complete medium, use 01-190- use medium, complete 100ml of preparation the For 1B with 01-192-1D. water 37ºC a in swirling by Supplement BIOAMF-1 the Thaw Instructions for Use‭ for Instructions 01-190- use medium, complete 500ml of preparation the For 1A with 01-192-1E. The medium consists of two components: basal medium supplements. and frozen villi for use in karyotyping. villi for No supplementation with serum or serum-substitutes is necessary. amniotic fluidcells and chorionic villi in (CV) samples both open (5% CO chorionic or amniocytes of growth rapid allows medium The BIOAMF-1 is designed for the primary culture of human Name Product ‭ and Supplement Basal Medium ‭ ‬ ‭ BIOAMF-1 BIOAMF-1 Basal Medium BIOAMF-1 Supplement

Prenatal Diagnostics 4 Prenatal Diagnostics BIOAMF-3 Instructions for use of BIOAMF-1,2,3 Complete Medium For Increased metaphase yield BIOAMF Medium may be used for: • Primary culture of amniotic fluid cells Product Name Cat. No. Unit Size • Culture of passaged amniotic fluid cells • Propagation of chorionic villus cells BIOAMF-3 01-196-1A 500ml Complete Medium 01-196-1B 100ml In Situ Culture of Amniotic Fluid Cells 1. Centrifuge 20ml of amniotic fluid at 750 rpm for 10 minutes. An improved version of complete medium specifically 2. Carefully decant the amniotic fluid from the cell pellet optimized for the primary culture of human amniotic fluid into a sterile test tube. cells and chorionic villi samples used in prenatal diagnostic 3. Re-suspend the cell pellet with 2ml of amniotic fluid. testing. 4. Add 2ml of BIOAMF Medium and swirl gently. This medium accelerates the growth of the non-epithelial 5. Culture 0.5ml of the cell suspension on each coverslip cells used for chromosome karyotyping. in a tissue culture dish. The medium is supplied frozen and contains L-Glutamine 6. Incubate cultures at 37°C in 5% CO2 atmosphere. and antibiotics. 7. Flood cultures on day 2 with 1.5ml of BIOAMF Medium. 8. After 5 days, check the cultures for the presence of Storage and Stability colonies. BIOAMF-3 Medium should be kept frozen at -20ºC. After 9. After the colonies first appear (5-7 days), replace the thawing, the medium should be stored at 2-8ºC. The medium medium with fresh BIOAMF Medium. should be used within 14 days after thawing. Protect the 10. When the cultures have colonies of sufficient size, proceed medium from light. with harvesting. If required‭, ‬after thawing at R.T or 4°C‭ (‬recommended‭), Note: It is recommended to replace the medium with fresh dispense into aliquots to avoid repeated freezing and thawing BIOAMF Medium the day before harvesting. cycles‭. ‬ Flask Method Culture of Amniotic Fluid Cells – Open and Closed Systems Use the same procedure as for the in situ culture, with the following adaptations: 1. Re-suspend the cell pellet with 4ml of amniotic fluid. Add 16ml of BIOAMF Medium and swirl gently. 2. Culture 5ml per each T25 flask. Place the cap loosely on the flask and incubate undisturbed at 37°C in 5% CO2 atmosphere. For Closed Systems: Flush each culture flask with 5% CO2 – 95% air through 0.2μ sterile filter for 20 seconds. Tighten the caps and incubate the flasks at 37°C. 3. Check all flasks for growth after 5 days.

5 ‭), ‬recommended ‭ ( ‬after thawing at R.T or 4°C ‭, . ‬ Inoculate approximately 0.5ml of bone marrow 0.5ml of bone marrow approximately Inoculate plate culture tube or tissue a plastic suspension into mix to tubes gently with 10ml of medium. Invert specimen. 72 hours. up to for the culture Incubate Solution (Cat.No. 12-004- Add 0.1-0.2ml of Colcemid an for the culture Incubate tube. each culture 1) to additional 15-30 minutes. tube and spin at a centrifuge to the culture Transfer 5 minutes. 500g for in the cells and re-suspend the supernatant Remove (Cat. No. 12-005-1). 0.075M KCl 5-10ml of hypotonic 10-12 minutes. at 37ºC for Incubate 5 minutes. Spin at 500g for sediment the cellular agitate the supernatant, Remove fixative ice-cold 5-10ml of fresh, and add drop-by-drop 3 parts methanol. to acid made up of 1 part acetic 10 minutes. in 4ºC for Leave 6 and 7. Repeat steps 0.5-1ml in a small volume pellet Re-suspend the cell to air slide and allow a clean onto drop fixative, of fresh dry. the or Giemsa. Giemsa banding has become Orecin common The most used technique. widely most slides with treat is to this staining obtain method to 10X (Cat.No. 03-051-5). Trypsin-EDTA Instructions for use for Instructions to method was developed karyotyping The bone marrow abnormalities. about chromosomal information provide of the culture for medium is intended The ready-to-use or conditioned without any mitogens cells bone marrow is added to inhibitor a mitotic 48-72 hours, medium. After After stage. in the metaphase mitosis stop to the culture staining, and solution, fixation by hypotonic treatment and observed be microscopically can chromosomes abnormalities. for evaluated 1. 2. 3. 4. 5. 6. 7. 8. 9. with be stained can the preparation 10. At this stage, and Stability Storage frozen Medium should be kept Karyotyping Bone Marrow at -20ºC. at 2-8ºC. thawing, the medium should be stored After thawing and freezing repeated avoid to aliquots into dispense ‭ cycles thawing. The medium should be used within 10 days after light. the medium from Protect If required 500ml 100ml Unit Size 01-199-1A 01-199-1B Cat. No.

Bone Marrow Culture Bone Marrow Bone Marrow Medium Karyotyping medium Without conditioned Bone Marrow Karyotyping Medium is intended for use in for Medium is intended Karyotyping Bone Marrow for cells of primary bone marrow cultivation short-term evaluation. chromosome Medium is based on RPMI-1640 Karyotyping Bone Marrow foetal with L-Glutamine, basal medium supplemented The medium serum, and antibiotics (Gentamicin). bovine medium. or conditioned any mitogens does not contain Medium is supplied as frozen Karyotyping Bone Marrow thawing. use after for medium, which is ready Medium Name Product Bone Marrow Karyotyping Karyotyping Bone Marrow Postnatal Diagnostics Postnatal Cytogenetic analysis of human hematopoietic cells cells of human hematopoietic analysis Cytogenetic in practice is a standard aspirates using bone marrow and processing improvements Cell culture hematology. of a number of the identification enabled have techniques and hematologic abnormalities in solid tumors recurring available are data more But even malignant diseases. solid tumors than for and lymphomas leukemias for or bone marrow ease of obtaining of the relative because patients. leukemia specimens from blood peripheral abnormalities in leukemia of chromosomal The study functions: two serves diagnosis, accurate in more to assist is The first and allowing information prognostic providing thereby a particular for of therapy selection rational the more of consistent the sites identify is to patient. The second localization the precise providing rearrangements, these of DNA from the isolation and cloning for required the the function of techniques Using molecular regions. whereby be identified and the mechanisms genes can be can in tumorigenesis is involved function their altered determined. of analysis that cytogenetic it was assumed In the past, performed was best malignant disorders hematologic However, samples. bone marrow on uncultured directly samples of cultured that analysis indicate studies later been not have abnormality that would a clonal disclosed had been used. alone method if the direct detected rearrangements chromosomal many samples, Thus, for of cultured analysis after only characterized often were preparations.

Postnatal Diagnostics - Bone Marrow Culture 6 Postnatal Diagnostics - Bone Marrow Culture 7 ), 0.10 <0.01 0.2 0.3 0.6 0.8 1.8 2.2 0.9 1.7 1.2 1.0 with 10% CM ‭ recommended (‬ 0.05 <0.01 0.01 0.01 0.02 0.03 0.08 0.12 0.08 0.10 0.02 0.02 culture after w/o CM 0.01 <0.01 0.01 <0.01 0.01 <0.01 0.02 <0.01 0.01 <0.01 0.01 <0.01 Before Culture . The medium should be used within 10 BM PB BM PB BM PB BM PB BM PB BM PB Source after thawing at R.T or 4°C‭ after , ‬ to each culture tube. Incubate the culture for an for the culture tube. Incubate each culture to additional 15-30 minutes. at tube and spin a centrifuge to the culture Transfer minutes. 5 500g for in the cells and re-suspend the supernatant Remove (Cat.No. 12-005-1). KCl 0.075M 5-10ml of hypotonic 10-12 minutes. at 37ºC for Incubate 5 minutes. Spin at 500g for sediment the cellular agitate the supernatant, Remove fixative ice-cold 5-10ml of fresh, and add drop-by-drop 3 parts methanol. to acid made up of 1 part acetic 10 minutes. in 4ºC for Leave 6 and 7. Repeat steps 5 minutes. Spin at 500g for to slide and allow a clean onto drop fixative, of fresh air dry. the Giemsa banding has become or Giemsa. Orecin common The most used technique. widely most slides with treat is to this staining obtain method to 10X (Cat. No. 03-051-5). Trypsin-EDTA

NORMAL

APL

AMML

AML

CML-BC

CML Diagnosis 4. 5. 6. 7. 8. 9. 0.5-1ml in a small volume pellet 10. Re-suspend the cell with be stained can the preparation 11. At this stage, and Stability Storage Medium should be kept Cell Karyotyping Hematopoietic at -20ºC. frozen at 2-8ºC. thawing, the medium should be stored After ‭ If required and freezing repeated avoid aliquots to ‬dispense into ‭ thawing cycles light. the medium from thawing. Protect days after Blood and Peripheral of Marrow Index Mitotic Table: for cultured Cells were Culture. and After Cells Before 4 days with or without 10% CM. 500ml 100ml Unit Size 01-200-1A 01-200-1B Cat. No. Ficoll-separated peripheral peripheral Ficoll-separated 7 Inoculate approximately 0.5ml of bone marrow 0.5ml of bone marrow approximately Inoculate suspension or 0.5-1x10 blood cells into a plastic tube or tissue culture plate plate culture tube or tissue a plastic into cells blood mix to tubes gently with 10ml of medium. Invert specimen. 72 or 120 hours. up to for the culture Incubate Solution (Cat.No. 12-0041) Add 0.1-0.2ml of Colcemid Hematopoietic Cell Hematopoietic Medium Karyotyping medium With conditioned 1. Instructions for use for Instructions method was developed karyotyping cell The hematopoietic abnormalities. about chromosomal information provide to and medium, acute of a conditioned In the presence in bone marrow cells leukemic nonlymphocytic chronic into enter to stimulated are cultures blood and peripheral a mitotic 24-72 hours, After by DNA replication. mitosis in the mitosis stop to the culture is added to inhibitor stage. metaphase solution, fixation and by hypotonic treatment After observed be microscopically can chromosomes staining, abnormalities. for and evaluated Cytogenetic analysis of human hematopoietic cells cells of human hematopoietic analysis Cytogenetic in practice is a standard aspirates using bone marrow in short-term grown or cells cells Fresh hematology. cells an insufficient number of mitotic yield often cultures Hematopoietic required. are aspirations and repeated the stimulate to Medium was developed Cell Karyotyping bone from cells of human hematopoietic proliferation blood. as peripheral as well marrow of karyotyping for effective This medium is particularly stages and various leukemias non-lymphocytic acute as other as well leukemia, myelogenous of chronic such as myelodysplastic disorders hematological Cell Hematopoietic vera. and polycythemia syndrome Medium is based on MEM-Alpha basal Karyotyping bovine foetal with L-Glutamine, medium supplemented medium. and conditioned serum, antibiotics (gentamicin) Medium with Conditioned Medium Medium with use in hematological for developed Specially and Index the Mitotic improves Significantly karyotyping. use with samples Designed for growth. cell accelerates Mitotic and/or low of cells amount a low which contain patients. and/or leukemia e.g. children Index, Bone Marrow Karyotyping Karyotyping Bone Marrow 2. 3. Product Name Product ‭), Unit Size 500ml 100ml ‬recommended ‭ ( Cat. No. 01-200-1A 01-200-1B ‬after thawing at R.T or 4°C ‭, . Inoculate approximately 0.5ml of Peripheral Blood Blood 0.5ml of Peripheral approximately Inoculate with 10ml of plate culture tube or tissue a plastic into mix specimen. to tubes gently medium. Invert of 72 hours. total for the culture Incubate No. 12-004- Solution (Cat. Add 0.1-0.2ml of Colcemid an for the culture tube. Incubate each culture 1) to additional 15-30 minutes. at tube and spin a centrifuge to the culture Transfer minutes. 5 500g for in the cells and re-suspend the supernatant Remove (Cat. No. 12-005-1). 0.075M KCl 5-10ml of hypotonic 10-12 minutes. at 37ºC for Incubate 5 minutes. Spin at 500g for sediment the cellular agitate the supernatant, Remove fixative ice-cold 5-10ml of fresh, and add drop-by-drop 3 parts methanol. to acid made up of 1 part acetic 10 minutes. in 4ºC for Leave 6 and 7. Repeat steps 0.5-1ml in a small volume pellet Re-suspend the cell to air slide and allow a clean onto drop fixative, of fresh dry. the Giemsa banding has become or Giemsa. Orecin common The most used technique. widely most slides with treat is to this staining obtain method to 10X (Cat. No. 03-051-5). Trypsin-EDTA Specially developed for use in hematological use in hematological for developed Specially and Index the Mitotic improves Significantly karyotyping. use with samples Designed for growth. cell accelerates Mitotic and/or low amount of cells a low which contain patients. and/or leukemia e.g. children Index, Peripheral Blood Blood Peripheral with Medium Karyotyping Conditioned Medium If required thawing and freezing repeated avoid to aliquots into ‬dispense ‭ cycles thawing. The medium should be used within 10 days after light. the medium from Protect 1. 2. 3. 4. 5. 6. 7. 8. 9. with be stained can the preparation 10. At this stage, and Stability Storage at -20ºC. frozen Medium should be kept PB Karyotyping at 2-8ºC. thawing, the medium should be stored After Hematopoietic Cell Hematopoietic Medium Karyotyping medium With conditioned Product Name Product Unit Size 500ml 100ml 500ml 100ml

Cat. No. 01-198-1B 01-201-1A 01-201-1B 01-198-1A Blood Lymphocyte Culture Lymphocyte Blood Peripheral Blood Blood Peripheral Medium Karyotyping With Phytohemagglutinin-M Blood Peripheral Medium Karyotyping Without Phytohemagglutinin-M Product Name Product Instructions for use for Instructions Media without Karyotypung Blood use of Peripheral For : PHA-M (Cat.No. 01-198-1) only Add 2-4ml of PHA-M (Cat.No. 12-009-1H) per 100ml PB Medium. Karyotyping Peripheral Blood (PB) Karyotyping Medium is specifically Medium is specifically (PB) Karyotyping Blood Peripheral blood of peripheral culture short-term optimized for No addition of analysis. chromosome for lymphocytes The medium or antibiotics is required. serum, glutamine is supplied frozen. Karyotyping Medium Karyotyping Peripheral Blood Blood Peripheral Advantages time • Saves promotion growth • Excellent required • No other supplements Blood cell karyotyping is an important tool in modern tool is an important karyotyping cell Blood about information providing human cytogenetics, in the abnormalities, their frequency chromosomal specific between relationship population, and the effects. abnormalities and phenotypic chromosomal of the examination involve studies Human cytogenetic division at cell blocking after lymphocyte a stimulated The formation. of spindle with an inhibitor metaphase and chromosome down breaks membrane nuclear usual, but the chromosomes as place takes condensation plate. a metaphase into themselves organize to fail a natural unlike quite an appearance This gives the within free are in that the chromosomes metaphase, allows and staining Subsequent processing cytoplasm. visualization of the chromosomes. clear either by a technique be stained can The chromosomes or by a technique intensity, uniform a fairly that gives of the the length along staining differential that gives chromosome.

Postnatal Diagnostics - Blood Lymphocyte Culture 8 Postnatal Diagnostics - Blood Lymphocyte Culture Cytogenetic analysis of human hematopoietic cells 11. At this stage, the preparation can be stained with using bone marrow aspirates is a standard practice in Orecin or Giemsa. Giemsa banding has become the hematology. Fresh cells or cells grown in short-term most widely used technique. The most common cultures often yield an insufficient number of mitotic cells method to obtain this staining is to treat slides with and repeated aspirations are required. Hematopoietic Trypsin-EDTA 10X (Cat. No. 03-051-5). Cell Karyotyping Medium was developed to stimulate the proliferation of human hematopoietic cells from bone Storage and Stability marrow as well as peripheral blood. Hematopoietic Cell Karyotyping Medium should be kept This medium is particularly effective for karyotyping of frozen at -20ºC. acute non-lymphocytic leukemias and various stages After thawing, the medium should be stored at 2-8ºC. of chronic myelogenous leukemia, as well as other The medium should be used within 10 days after thawing. hematological disorders such as myelodysplastic Protect the medium from light. syndrome and polycythemia vera. Hematopoietic Cell Karyotyping Medium is based on MEM-Alpha basal The mitotic index of peripheral blood myeloid leukemic medium supplemented with L-Glutamine, foetal bovine cells in culture. Peripheral blood cells from three patients serum, antibiotics (gentamicin) and conditioned medium. with AML were isolated on Ficoll Hypaque and cultured either in the presence (full symbols) or absence (empty Instructions for use symbols) of 10% CM. The hematopoietic cell karyotyping method was developed to provide information about chromosomal abnormalities. Figure: The mitotic index of peripheral blood myeloid In the presence of a conditioned medium, acute and leukemic cells in culture with or without conditioned chronic nonlymphocytic leukemic cells in bone marrow medium‭. and peripheral blood cultures are stimulated to enter into Peripheral blood cells from three patients with AML mitosis by DNA replication. After 48-72 hours, a mitotic were isolated on FicollHypaque and cultured either in inhibitor is added to the culture to stop mitosis in the the presence (Turquoise) or absence (Gray) of CM. metaphase stage. After treatment by hypotonic solution, fixation and staining, chromosomes can be microscopically observed and evaluated for abnormalities.

1. Inoculate approximately 0.5ml of peripheral blood 1 or 0.5-1x107 Ficoll-separated peripheral blood cells into a plastic tube or tissue culture plate with 10ml of medium. Invert tubes gently to mix specimen. 2. Incubate the culture for up to 72 or 120 hours. 3. Add 0.1-0.2ml of Colcemid Solution (Cat.No. 12-0041) to each culture tube. Incubate the culture for an 0.5 additional 15-30 minutes. Mitotic Index (%) Index Mitotic 4. Transfer the culture to a centrifuge tube and spin at 500g for 5 minutes. 5. Remove the supernatant and re-suspend the cells in 5-10ml of hypotonic 0.075M KCl (Cat.No. 12-005-1). Incubate at 37ºC for 10-12 minutes. 0.01 6. Spin at 500g for 5 minutes. 0 1 2 3 4 5 7. Remove the supernatant, agitate the cellular sediment Days in Culture and add drop-by-drop 5-10ml of fresh, ice-cold fixative made up of 1 part acetic acid to 3 parts methanol. Cells cultured in the presence of 10% CM. Leave in 4ºC for 10 minutes. 8. Repeat steps 6 and 7. Cells cultured in the absence of CM. 9. Spin at 500g for 5 minutes. 10. Re-suspend the cell pellet in a small volume 0.5-1ml of fresh fixative, drop onto a clean slide and allow to air dry. 9 Lymphocyte Separation Tubes Postnatal Diagnostics - Blood Lymphocyte Culture EZ Lympho-Sep™ precautions required to prevent disruption of the polysucrose - sodium metrizoate layer. Thus, a large number of samples may be handled at the same time. The mechanism also reduces Preparation of separation tubes is time consuming the length of centrifugation time required for separation of and their application is technically difficult. The the lymphocytes. EZ Lympho-Sep™ provide, a competitively priced ready-for-use alternative to the “home made” Features: blood separation tube. • Ready-to-use, sterile. • Safe method, minimum contact with biological fluids. Principal areas requiring lymphocyte assessment • Time saver, quick and easy sample filling. • Maximum yield of viable mononuclear cells. • ‏The determination of malignant proliferation • A large number of samples may be handled at the same • ‏ Suspected deficiency of the immune system time • ‏ Wide variety of acute and chronic diseases associated with evidence of some alteration in the immune system ‏EZ Lympho-Sep™ tubes are manufactured with either 2 or 3 ml separation medium in 15 ml centrifuge tubes or with either ‏Isolation of lymphocytes from peripheral blood 10 or 15 ml separation medium in 50 ml centrifuge tubes. ‏The most commonly used procedure is for separation of the For laboratories that have stocks of Ficoll or Lymphoprep, mononuclear cells by density gradient centrifugation of whole the tubes can be ordered empty for charging with separation blood. This procedure is performed by carefully layering medium immediately before use. diluted whole blood over a polysucrose - sodium metrizoate medium (Ficoll-Paque, Lymphoprep, Histopaque, etc). The diluted blood is added to the gradient by gently pipetting with Ready-for-use cell separation tubes the tubes held at an angle or by pouring the blood onto the ‏The heart of the EZ Lympho-Sep™ is a plastic insert that separation medium. This latter method requires considerable allows the blood sample to be poured directly into the tube practice and is not recommended for beginners. To obtain alleviating the need for slow and careful addition of the blood. good separations, it is critical that a clear separation be kept Secondly, a one-way feature of the insert allows passage between the dense polysucrose - metrizoate and the blood of materials during the centrifugation step but prevents layer before centrifugation. the flow of the separation medium during shipping. After ‏Due to the extreme care that must be exercised when pipetting centrifugation, if desired, the upper lymphocyte-containing blood on to the separation medium, alternative methods fraction may be poured off without risk of contamination have been devised. In one such procedure a sample of the from the erythrocytes, which are trapped under the insert. diluted blood is placed in a centrifuge tube and Ficoll-Paque (or equivalent separation medium with a density of 1.077) is added by being underlayered under the blood. This method creates cleaner interfaces than those obtained when blood is layered over the Ficoll, since there is less disturbance of the surface of the Ficoll and less mixing.

‏ ‏Unique density gradient separation of lymphocytes from whole blood Density gradient centrifugation of whole blood on a polysucrose - sodium metrizoate medium is the method of choice for isolation of lymphocytes. The success of the procedure, i.e. the recovery of viable lymphocytes with the lowest proportion of contaminating granulocytes and erythrocytes, depends to a large extent on the careful layering of the blood sample onto the separation medium and the maintenance of a sharp interface between the two solutions prior to centrifugation. The EZ Lympho-Sep™ system allows the blood sample to be poured directly into the centrifuge tube with no special

10 Postnatal Diagnostics - Blood Lymphocyte Culture Buffy Booster for EZ Lympho-Sep™ Catalog No. 01-899-U15

DENSITY GRADIENT LYMPHOCYTE SEPARATION FROM BIOLOGICAL FLUIDS HAVING LOW RED CELL CONTENT

Critically important to the function of ready-to-use lymphocyte separation tubes (such as EZ Lymph-Sep™) is the hematocrit, i.e. the volume of the blood fluid occupied by the red blood cells. It is this mass of cells that during the centrifugation procedure displaces the sodium metrizoate – polysucrose so that it rises above the centrifugation device to form a density layer at which the white cells collect. In cases where sufficient red cells are not present, the sodium metrizoate - polysucrose interface forms at or even below the level of the separation device. In this situation recovery of the white cell fraction may not be possible. Diluted whole blood, buffy coat (enriched white cell fraction), bone marrow, lymph and spinal fluid are all examples of this type of biological fluids. When there is not sufficient red cell mass in the sample itself to displace the sodium metrizoate - polysucrose to the required level, extra mass must be added. Buffy Booster, a dense inert liquid, immiscible in water, is added prior to centrifugation. Centrifugal force causes Buffy Booster to sink to the bottom of the tube. Any red blood cells present form a sedimentation layer on top of the Buffy Booster (the red cell layer and Buffy Booster do not mix). The volume of sodium metrizoate - polysucrose displaced upwards is equal to the combined volumes of the Buffy Booster and the sedimented red cells. No contamination with red cells or Buffy Booster is possible even when the whole upper plasma layer is poured off. The red cells do not pass the separation device, while the Buffy Booster is blocked in by the red cell layer.

11 Postnatal Diagnostics - Blood Lymphocyte Culture Filled tubes:

Cat. No. Centrifuge Tube Separation Medium Diluted Blood (1:1) Undiluted Blood Packaging

01-899-‭-‬U0‭ ‬1 2ml Up to 8‭ ‬X 107cells 10‭ ‬Tubes/box For the preparation of T and B cells fractions‭: ‬Uni-sorb nylon wool column‭. ‬ ‭ 01-899-U02 15ml 2ml 4 - 8 ml 2 - 4 ml 30 Tubes/Box 01-899-U04 15ml 3ml 4-11 ml 2 - 5.5 ml 30 Tubes/Box 01-899-U10 50ml 10ml 20 -35 ml 10 -17.5 ml 18 Tubes/Box 01-899-U16 50ml 15ml not applicable 18.5-25 ml 18 Tubes/Box 01-899-U15 3‭/‬KIT‭ BUFFY BOOSTER KIT density gradient lymphocyte separation from biological fluids having low red cell content

Unfilled tubes:

Cat. No. Centrifuge Tube Separation Medium Diluted Blood (1:1) Undiluted Blood Packaging to be added 01-899-U03 15ml 2ml 4 - 8 ml 2 - 4 ml 30 Tubes/Box 01-899-U05 15ml 3ml 4-11 ml 2 - 5.5 ml 30 Tubes/Box 01-899-U11 50ml 10ml 20 -35 ml 10 -17.5 ml 18 Tubes/Box 01-899-U17 50ml 15ml not applicable 18.5-25 ml 18 Tubes/Box

1 2 3 4 EZ Lympho-Sep™ Tube After the After Remove ready for use addition of blood centrifugation cells with pipette Decant by inverting the tube or Plasma Plasma Lymphocyte Lymphocyte Then wash with Separtion band band fresh growth device medium or buffer Separtion Precipitated Precipitated fluid red cells red cells

Instructions for use: leukocytes or granulocytes) are found at the bottom 1. EZ Lympho-SEP products are sterile and ready for use. of the tube. The EZ LYMPHO-SEP insert separates Open only under aseptic conditions. the lymphocyte interface from the pellet of packed 2. Best results are obtained when all steps are performed erythrocytes. at 18-20°C. 4. Remove the platelet-rich plasma and discard it. 3. Use anticoagulant treated or defibrinated blood. Blood 5. Remove the mononuclear layer with the aid of a pipette. may be diluted with an equal volume of sterile saline or Alternatively, the entire contents of the tube above the other sterile isotonic buffer or may by used undiluted. Add plastic insert may be removed by decanting the solution. diluted or undiluted blood, according to Table I directly to the tube, cap and centrifuge Storage: Store at 4-25°C out of direct light. Deterioration (18-20°C) 1000 x g for 20 min. Procedures carried out at of the polysucrose - sodium metrizoate is indicated by the lower temperature may require longer centrifugation. appearance of a distinct yellow color or particulate material Erythrocytes, dead cells and PMNs (polymorph nuclear in the clear solution.

12 Karyotyping Reagents Karyotyping Reagents Phytohemagglutinin M (PHA-M) Colchicine Solution 10µg/ml in DPBS Product Name Cat. No. Unit Size Product Name Cat. No. Unit Size Phytohemagglutinin-M 12-006-1H 5ml (PHA-M), Lyophilized Colchicine Solution, 12-003-1C 25ml 10µg/ml in DPBS Phytohemagglutinin-M 12-009-1H 5ml (PHA-M), Liquid, See Colcemid (Demecolcine) Solutions (p.14) Ready-to-use

Phytohemagglutinin is a lectin extracted from red kidney Potassium Chloride 0.075 Molar beans (Phaseolus vulgaris). The protein consists of two molecular species, a leucoagglutinin (PHA-L) and an Product Name Cat. No. Unit Size erythroagglutinin (PHA-E). Each of the proteins contains a family of five isolectins, each being a tetramer held Potassium Chloride, 12-005-1B 100ml together by noncovalent forces. PHA-M is the mucoprotein 0.075 Molar form and is a crude extract used for the stimulation of cell proliferation in lymphocyte culture. PHA-M also A major step in harvesting cells for chromosome has a powerful erythroagglutinating property and it was karyotyping is treatment with a hypotonic saline solution originally used for separating leukocytes from whole to increase cell volume. Hypotonic solutions work by blood. creating a concentration gradient across the cytoplasmic PHA-M from Biological Industries is sterile. Each lot is membrane and water then rushes in by active transport. tested and standardized for mitotic stimulation using A hypotonic solution of potassium chloride in water for primary human peripheral blood lymphocytes. use in the preparation of blood lymphocyte chromosomes‭ - ‬the hypotonic‭ ‬treatment causes the cells to swell‭. ‬ Hypotonic KCl and Sodium citrate are used most frequently‭. ‬Both room temperature and 37°C are used‭. Colcemid (Demecolcine) ‬Generally‭, ‬the higher‭ ‬temperature is used to increase Solution, 10µg/ml in DPBS metaphase spreading‭. ‬The time of exposure will depend on cell density and type of specimen‭, ‬whether on slides or Product Name Cat. No. Unit Size in a cell pellet.‭ ‬Generally‭, ‬the type of hypotonic treatment is determined empirically in a particular laboratory and‭ ‬ Colcemid Solution, 12-004-1D 10ml may need to be modified from time to time.‭ ‬ 10µg/ml in DPBS

Colcemid, N-deacetyl-N-methylcolchicine, is related to colchicine, but animal studies found it to be much less toxic. Colcemid arrests mitotic cultured cells in metaphase and it should be treated with care, since it is mutagenic, tumorigenic, and teratogenic. Colcemid Solution from Biological Industries is prepared in PBS and it is recommended to use a concentration of 0.1µg/ml in culture medium. Colcemid is recommended for use in chromosome analysis during lymphocyte karyotyping and amniotic fluid cell chromosome analysis, and in cell synchronization.

Colcemid Solution should be stored at 2-8ºC, protected from light.

13 Karyotyping Reagents Sodium Citrate Solution (0.8%) Cell Synchronization Kit

Product Name Cat. No. Unit Size For high-resolution cytogenetic analysis

Product Name Cat. No. Unit Size Sodium Citrate Solution 01-934-1A 500ml (0.8%) Cell Synchronization Kit 12-008-60 60 reactions

Sodium Citrate Solution is a hypotonic solution, utilized for The blood cell karyotyping method was developed to the preparation of blood lymphocyte chromosomes. provide information about chromosomal abnormalities. Lymphocyte cells do not normally undergo subsequent Hypotonic treatment with Sodium Citrate is used most cell divisions. In the presence of a mitogen, lymphocytes often with the addition of Potassium Chloride (KCl) to are stimulated to enter into mitosis by DNA replication. enhance membrane permeability and induce hypotonic After 48-72 hours, a mitotic inhibitor is added to the cell swelling at either room temperature (15-30°C) or culture to stop mitosis in the metaphase stage. After 37°C. Usually, the higher temperature is used to increase treatment by hypotonic solution, fixation and staining, metaphase spreading. chromosomes can be microscopically observed and evaluated for abnormalities. Features: High resolution analysis is a special manipulation of the • Sterile routine blood karyotyping procedure designed to provide • Easy-to-use a large number of mitotic figures in late prophase or • Increases metaphase spread of Peripheral Blood prometaphase. At this stage of mitosis the chromosomes Lymphocytes (PBL’s) are longer and less condensed. After G-banding, the chromosomes will show greater level of band resolution not seen in routine analysis. High resolution allows more Trypsin EDTA (0.5%), EDTA 0.2%, detailed analysis of the karyotype. Cultures can be synchronized by the addition of 10X Conc. methotrexate (MTX), an inhibitor of thymidine biosynthesis which blocks cells in the S-phase (DNA synthesis) of the Product Name Cat. No. Unit Size cell cycle. After 16-18 hours, most of the dividing cells in the cuture are in the S-phase. If thymidine is added to the Trypsin EDTA (0.5%), 03-051-5B 100ml culture, the MTX block is released and the cells proceed EDTA 0.2% , 10X Conc. 03-051-5C 20ml synchronously to mitosis, at which point colcemid may be added. A very short colcemid treatment in conjuction Giemsa banding has become the most widely used with this technique may be used to produce extended technique for the routine staining of chromosomes. The prometaphase chromosomes when small deletions or most commonly used method to obtain this staining is rearrangements are suspected. to treat slides with trypsin. This procedure allows for chromosome digestion and high resolution staining. Materials 1. Methotrexate (Amethopterin), 10-5M in HBSS: 4 vials Trypsin-EDTA 10X from Biological Industries contains containing 1.5ml each Trypsin (1:250) 5gr per liter, and EDTA 2gr per liter. 2. Thymidine, 10-3M in distilled water: 4 vials containing Store at -20ºC. 1.5ml each

Storage and Stability The solutions must be kept frozen and protected from light. If appropriately stored, the solutions are stable for at least 18 months from the date of preparation.

14 Appendix Product Name Cat. No. Unit Size Storage Temp.

Prenatal BIOAMF-1 01-190-1A 450ml 2-8ºC Diagnostics Basal Medium 01-190-1B 90ml 2-8ºC BIOAMF-1 01-192-1D 10ml -20ºC Supplement 01-192-1E 50ml -20ºC BIOAMF-2 01-194-1A 500ml -20ºC Complete Medium 01-194-1B 100ml -20ºC BIOAMF-3 01-196-1A 500ml -20ºC Complete Medium 01-196-1B 100ml -20ºC

Postnatal Bone Marrow Culture Diagnostics Bone Marrow Karyotyping Medium, 01-199-1A 500ml -20ºC without conditioned medium 01-199-1B 100ml -20ºC Hematopoietic Cell Karyotyping Medium, 01-200-1A 500ml -20ºC with conditioned medium 01-200-1B 100ml -20ºC Blood Lymphocyte Culture Peripheral Blood Karyotyping Medium, 01-198-1A 500ml -20ºC without Phytohemagglutinin 01-198-1B 100ml -20ºC Peripheral Blood Karyotyping Medium, 01-201-1A 500ml -20ºC with Phytohemagglutinin 01-201-1B 100ml -20ºC Hematopoietic Cell Karyotyping Medium, 01-200-1A 500ml -20ºC with conditioned medium 01-200-1B 100ml -20ºC Lymphocyte Separation Tubes EZ-Lympho-Sep™ See page 13

Colchicine Solution, 10µg/ml in DPBS 12-003-1C 25ml 2-8ºC Colcemid Solution, 10µg/ml in DPBS 12-004-1D 10ml 2-8ºC Potassium Chloride, 0.075 Molar 12-005-1B 100ml 2-8ºC

Karyotyping Sodium Citrate Solution (0.8%) 01-934-1A 500ml RT Reagents Phytohemagglutinin-M (PHA-M), Lyophilized 12-006-1H 5ml 2-8ºC Phytohemagglutinin-M (PHA-M), 12-009-1H 5ml -20ºC Liquid, Ready-to-use Cell Synchronization Kit 12-008-60 60 reactions -20ºC Trypsin EDTA (0.5%), EDTA 0.2% , 10X Conc. 03-051-5B 100ml -20ºC 03-051-5C 20ml -20ºC

15 NettaDavids E29/4 9/16 Biological Industries Israel Beit Haemek Ltd. Haemek Beit Israel Industries Biological Israel 25115, Haemek Beit Kibbutz F.+972.4.9968896 T.+972.4.9960595 [email protected] Email: